THURSDAY, Dec. 11, 2025 — Federal regulators have begun a safety review of two RSV medicines used to protect infants, even though no safety problems have been reported.
The review covers Beyfortus (from Sanofi and AstraZeneca) and Enflonsia…
Blog
Leave a Reply